|
Prevalence of HRR gene mutations in patients with metastatic castration-resistant prostate cancer: Germline results from the Latin-American observational study PROSPECT. |
|
|
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Grupo Biotoscana; Ipsen; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Tecnofarma |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Grupo Biotoscana; Ipsen; Janssen; Lilly; MSD; Pfizer; Tecnofarma |
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Tecnofarma |
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Grupo Biotoscana; Ipsen; Janssen; Lilly; MSD; Novartis; Pfizer; Roche; Tecnofarma |
Expert Testimony - Astellas Pharma; Bayer; Janssen; MSD |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; MSD |
|
|
Honoraria - AstraZeneca; Janssen; Roche |
Speakers' Bureau - AstraZeneca; Janssen; Roche |
Research Funding - AstraZeneca; AstraZeneca (Inst) |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Roche |
Consulting or Advisory Role - Astellas Pharma; Ipsen; Roche |
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; MSD; Roche |
Research Funding - AstraZeneca (Inst) |
Expert Testimony - AstraZeneca; Bristol-Myers Squibb; MSD; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Raffo |
|
|
Consulting or Advisory Role - AstraZeneca |
Speakers' Bureau - AstraZeneca |
Research Funding - AstraZeneca |
|
|
Honoraria - Astellas Pharma; AstraZeneca; AstraZeneca; Bayer |
Speakers' Bureau - AstraZeneca; Bayer; Bristol-Myers Squibb; Pfizer |
Research Funding - Bayer; Bristol-Myers Squibb; Pfizer (Inst) |
|
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Merck; Merck Serono; Pfizer |
|
|
|
Consulting or Advisory Role - AstraZeneca |
Speakers' Bureau - AstraZeneca |
Travel, Accommodations, Expenses - Janssen |
|
|
|
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca; AVEO; Bayer; BMS; Caris Life Sciences; Dendreon (Inst); Eisai; EMD Serono; Exelixis; Pfizer |
Speakers' Bureau - Bayer (Inst); Caris Life Sciences (Inst); Pfizer/Astellas (Inst) |
Research Funding - AVEO (Inst); Blue Earth Diagnostics (Inst); Merck (Inst); Pfizer (Inst) |